Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Aldosterone synthase alleles and cardiovascular phenotype in young adults

Abstract

The C(−344)T promoter polymorphism of the human aldosterone synthase (CYP11B2) gene has been associated with hypertension and cardiac hypertrophy, but there were contrasting data. We analysed the genotype/phenotype associations between this polymorphism and cardiovascular variables in a young adult population, where interactions among genes, gene–environment, and acquired ageing-related organ damage are reduced. Anthropometric measurements, blood pressure, heart rate, left ventricular variables (by echocardiography), and carotid artery wall intimal–media thickness (by high-resolution sonography and digitalized morphometry) were taken in 420 white Caucasian students (mean age 23.5 years, s.d. 2.5 years). CYP11B2 alleles were detected by genomic polymerase chain reaction followed by digestion. Taking into account the three possible models of inheritance, we found no differences in the considered variables, except for an independent effect of the C(−344) allele on SBP in males (TT 125.6 (1.6), TC 128.4 (1.2) and CC 130.5 (2.2), mmHg, media (ES), P=0.03), and on interventricular septum thickness in diastole in females (CC 6.98 (0.12) vs TT 6.87 (0.09) and TC 6.87 (0.07), mmHg, P<0.01), in the codominant model. In conclusion, the CYP11B2 C(−344)T polymorphism appears to have a slight role in the cardiovascular phenotype of young healthy adults, even if these genotype/phenotype relationships might change with ageing.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kupari M et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation 1998; 97: 569–575.

    Article  CAS  PubMed  Google Scholar 

  2. Schunkert H et al. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. Circulation 1999; 99: 2255–2260.

    Article  CAS  PubMed  Google Scholar 

  3. Brand E et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 1998; 32: 198–204.

    Article  CAS  PubMed  Google Scholar 

  4. Delles C et al. Aldosterone synthase (CYP11B2) −344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension. J Am Coll Cardiol 2001; 37: 878–884.

    Article  CAS  PubMed  Google Scholar 

  5. Sass C et al. Intima–media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. J Hypertens 1998; 16: 1593–1602.

    Article  CAS  PubMed  Google Scholar 

  6. Sarzani R et al. Cardiovascular phenotype of young adults and angiotensinogen alleles. J Hypertens 2001; 19: 2171–2178.

    Article  CAS  PubMed  Google Scholar 

  7. Devereux RB, Reicheck N . Echocardiographic determination of left ventricular mass in man. Circulation 1977; 55: 613–618.

    Article  CAS  PubMed  Google Scholar 

  8. De Simone G et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20: 1251–1260.

    Article  CAS  PubMed  Google Scholar 

  9. De Simone G et al. Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: the RES trial. Working Group on Heart and Hypertension of the Italian Society of Hypertension. Reliability of M-mode Echocardiographic Studies. J Hypertens 1999; 17: 1955–1956.

    Article  CAS  PubMed  Google Scholar 

  10. Tang R et al. Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima–media thickness: the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2000; 18: 197–201.

    Article  CAS  PubMed  Google Scholar 

  11. Cohen J . Statistical Power Analysis for the Behavioural Science. 2nd edn. LEA Publishers: New York, 1988.

    Google Scholar 

  12. Lindman HR . Analysis of Variance in Experimental Design, 1st edn. Springer Verlag: New York, 1992, p 62.

    Book  Google Scholar 

  13. Inoue I et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99: 1786–1797.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Cusi D et al. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997; 349: 1353–1357.

    Article  CAS  PubMed  Google Scholar 

  15. Sarzani R et al. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower ANP and higher blood pressure in obese hypertensives. J Hypertens 1999; 17: 1301–1305.

    Article  CAS  PubMed  Google Scholar 

  16. Taittonen L et al. Angiotensin converting enzyme gene insertion/deletion polymorphism, angiotensinogen gene polymorphisms, family history of hypertension, and childhood blood pressure. Am J Hypertens 1999; 12: 858–866.

    Article  CAS  PubMed  Google Scholar 

  17. Pitzalis MV et al. Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype. J Hypertens 2003; 21: 1491–1496.

    Article  CAS  PubMed  Google Scholar 

  18. Marenberg ME et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 1041–1046.

    Article  CAS  PubMed  Google Scholar 

  19. Doris PA . Hypertension genetics, single nucleotide polymorphisms, and common disease:common variant hypothesis. Hypertension 2002; 39: 323–331.

    Article  CAS  PubMed  Google Scholar 

  20. Ranade K et al. Genetic variation in aldosterone synthase predicts plasma glucose levels. Proc Natl Acad Sci USA 2001; 98: 13219–13224.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Davies E et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 1999; 33: 703–707.

    Article  CAS  PubMed  Google Scholar 

  22. Paillard F et al. Genotype–phenotype relationships for the renin–angiotensin–aldosterone system in a normal population. Hypertension 1999; 34: 423–429.

    Article  CAS  PubMed  Google Scholar 

  23. Castellano M et al. β2-Adrenergic receptor gene polymorphism, age, and cardiovascular phenotypes. Hypertension 2003; 41: 361–367.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R Sarzani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarzani, R., Salvi, F., Dessì-Fulgheri, P. et al. Aldosterone synthase alleles and cardiovascular phenotype in young adults. J Hum Hypertens 17, 859–864 (2003). https://doi.org/10.1038/sj.jhh.1001619

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001619

Keywords

This article is cited by

Search

Quick links